Found: 54
Select item for more details and to access through your institution.
Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Digestive Diseases, 2015, v. 16, n. 9, p. 505, doi. 10.1111/1751-2980.12267
- By:
- Publication type:
- Article
Increasing incidence of non-HBV- and non-HCV-related hepatocellular carcinoma: single-institution 20-year study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The impact of interferon‐free direct‐acting antivirals on clinical outcome after curative treatment for hepatitis C virus–associated hepatocellular carcinoma: Comparison with interferon‐based therapy.
- Published in:
- Journal of Medical Virology, 2019, v. 91, n. 4, p. 650, doi. 10.1002/jmv.25352
- By:
- Publication type:
- Article
Advanced liver fibrosis effects on the response to sofosbuvir‐based antiviral therapies for chronic hepatitis C.
- Published in:
- Journal of Medical Virology, 2018, v. 90, n. 12, p. 1834, doi. 10.1002/jmv.25267
- By:
- Publication type:
- Article
Emergence of drug resistance-associated variants and changes in serum lipid profiles in sofosbuvir plus ledipasvir-treated chronic hepatitis C patients.
- Published in:
- Journal of Medical Virology, 2017, v. 89, n. 11, p. 1963, doi. 10.1002/jmv.24885
- By:
- Publication type:
- Article
Efficacy and safety of daclatasvir plus asunaprevir therapy for chronic hepatitis C patients with renal dysfunction.
- Published in:
- Journal of Medical Virology, 2017, v. 89, n. 4, p. 665, doi. 10.1002/jmv.24679
- By:
- Publication type:
- Article
Reply from the authors.
- Published in:
- Hepatology Research, 2020, v. 50, n. 12, p. 1393, doi. 10.1111/hepr.13578
- By:
- Publication type:
- Article
Real‐world efficacy of sofosbuvir plus velpatasvir therapy for patients with hepatitis C virus‐related decompensated cirrhosis.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1234, doi. 10.1111/hepr.13555
- By:
- Publication type:
- Article
Impact of viral eradication by direct‐acting antivirals on the risk of hepatocellular carcinoma development, prognosis, and portal hypertension in hepatitis C virus‐related compensated cirrhosis patients.
- Published in:
- Hepatology Research, 2020, v. 50, n. 11, p. 1222, doi. 10.1111/hepr.13554
- By:
- Publication type:
- Article
Incidence of microsatellite instability‐high hepatocellular carcinoma among Japanese patients and response to pembrolizumab.
- Published in:
- Hepatology Research, 2020, v. 50, n. 7, p. 885, doi. 10.1111/hepr.13496
- By:
- Publication type:
- Article
Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 13, p. 1118, doi. 10.1111/hepr.13232
- By:
- Publication type:
- Article
Clinical outcomes of sorafenib treatment failure for advanced hepatocellular carcinoma and candidates for regorafenib treatment in real‐world practice.
- Published in:
- Hepatology Research, 2018, v. 48, n. 10, p. 814, doi. 10.1111/hepr.13180
- By:
- Publication type:
- Article
Risk factors for exacerbation of gastroesophageal varices and portosystemic encephalopathy during treatment with nucleos(t)ide analogs for hepatitis B virus‐related cirrhosis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 4, p. 264, doi. 10.1111/hepr.12996
- By:
- Publication type:
- Article
Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma.
- Published in:
- Hepatology Research, 2018, v. 48, n. 2, p. 193, doi. 10.1111/hepr.12916
- By:
- Publication type:
- Article
Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.
- Published in:
- Hepatology Research, 2018, v. 48, n. 1, p. 51, doi. 10.1111/hepr.12895
- By:
- Publication type:
- Article
Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid.
- Published in:
- Hepatology Research, 2017, v. 47, n. 10, p. 1053, doi. 10.1111/hepr.12844
- By:
- Publication type:
- Article
Liver fibrosis assessment by FibroScan compared with pathological findings of liver resection specimen in hepatitis C infection.
- Published in:
- Hepatology Research, 2017, v. 47, n. 8, p. 767, doi. 10.1111/hepr.12815
- By:
- Publication type:
- Article
Complete response to short-term sorafenib treatment alone for hepatocellular carcinoma with bone, lymph node, and peritoneum metastases.
- Published in:
- Hepatology Research, 2016, v. 46, n. 13, p. 1402, doi. 10.1111/hepr.12698
- By:
- Publication type:
- Article
Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C.
- Published in:
- Hepatology Research, 2016, v. 46, n. 12, p. 1256, doi. 10.1111/hepr.12681
- By:
- Publication type:
- Article
Three patients treated with daclatasvir and asunaprevir for recurrent hepatitis C after liver transplantation: Case report.
- Published in:
- Hepatology Research, 2016, v. 46, n. 7, p. 707, doi. 10.1111/hepr.12602
- By:
- Publication type:
- Article
Improvement of renal dysfunction in a patient with hepatitis C virus-related liver cirrhosis by daclatasvir and asunaprevir combination therapy: A case report.
- Published in:
- Hepatology Research, 2016, v. 46, n. 9, p. 944, doi. 10.1111/hepr.12629
- By:
- Publication type:
- Article
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 151, doi. 10.1159/000513706
- By:
- Publication type:
- Article
Early changes in ammonia levels and liver function in patients with advanced hepatocellular carcinoma treated by lenvatinib therapy.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48045-z
- By:
- Publication type:
- Article
Extracellular water to total body water ratio obtained by bioelectrical impedance analysis determines the dose intensity of lenvatinib for the treatment of patients with advanced hepatocellular carcinoma.
- Published in:
- Journal of Gastroenterology & Hepatology, 2021, v. 36, n. 6, p. 1685, doi. 10.1111/jgh.15377
- By:
- Publication type:
- Article
In vitro analysis of hepatic stellate cell activation influenced by transmembrane 6 superfamily 2 polymorphism.
- Published in:
- Molecular Medicine Reports, 2021, v. 23, n. 1, p. N.PAG
- By:
- Publication type:
- Article
Early experience of seven hepatocellular carcinoma cases treated with regorafenib.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Management of refractory ascites attenuates muscle mass reduction and improves survival in patients with decompensated cirrhosis.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury.
- Published in:
- 2017
- By:
- Publication type:
- journal article
ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Safety and efficacy of dual therapy with daclatasvir and asunaprevir for older patients with chronic hepatitis C.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The risk of transient postprandial oxyhypoglycemia in nonalcoholic fatty liver disease.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outcomes of Patients with Child-Pugh B and Unresectable Hepatocellular Carcinoma Undergoing First-Line Systemic Treatment with Sorafenib, Lenvatinib, or Atezolizumab Plus Bevacizumab.
- Published in:
- Oncology, 2024, v. 102, n. 3, p. 239, doi. 10.1159/000533859
- By:
- Publication type:
- Article
Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 507, doi. 10.1159/000515865
- By:
- Publication type:
- Article
Clinical Outcomes of 2nd- and 3rd-Line Regorafenib for Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2021, v. 99, n. 8, p. 491, doi. 10.1159/000515280
- By:
- Publication type:
- Article
Comparison of the Clinical Outcome of Ramucirumab for Unresectable Hepatocellular Carcinoma with That of Prior Tyrosine Kinase Inhibitor Therapy.
- Published in:
- Oncology, 2021, v. 99, n. 5, p. 327, doi. 10.1159/000514315
- By:
- Publication type:
- Article
Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2020, v. 98, n. 11, p. 787, doi. 10.1159/000509387
- By:
- Publication type:
- Article
Trends in Hepatic Functional Reserve of Patients with Hepatocellular Carcinoma Treated with Tyrosine Kinase Inhibitors.
- Published in:
- Oncology, 2020, v. 98, n. 10, p. 727, doi. 10.1159/000507815
- By:
- Publication type:
- Article
Correlation between Early Tumor Marker Response and Imaging Response in Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib.
- Published in:
- Oncology, 2019, v. 97, n. 2, p. 75, doi. 10.1159/000499715
- By:
- Publication type:
- Article
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis.
- Published in:
- Oncology, 2018, v. 94, n. 4, p. 215, doi. 10.1159/000486483
- By:
- Publication type:
- Article
Impact of Hepatitis C Virus Eradication on the Clinical Outcome of Patients with Hepatitis C Virus-Related Advanced Hepatocellular Carcinoma Treated with Sorafenib.
- Published in:
- Oncology, 2017, v. 92, n. 6, p. 335, doi. 10.1159/000458532
- By:
- Publication type:
- Article
Serum PreS1 and HBsAg ratio reflects liver fibrosis and predicts the development of hepatocellular carcinoma in chronic hepatitis B patients.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1304, doi. 10.1111/jvh.13557
- By:
- Publication type:
- Article
Abatacept treatment for patients with severe acute hepatitis caused by hepatitis B virus infection—Pilot study.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 2, p. 400, doi. 10.1111/jvh.13441
- By:
- Publication type:
- Article
Risk factors for histological progression of non‐alcoholic steatohepatitis analyzed from repeated biopsy cases.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1412, doi. 10.1111/jgh.14968
- By:
- Publication type:
- Article
Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
- Published in:
- Journal of Gastroenterology & Hepatology, 2018, v. 33, n. 10, p. 1780, doi. 10.1111/jgh.14152
- By:
- Publication type:
- Article